Vanda Pharmaceuticals, Inc. ( VNDA ) was a big mover last session as its shares rose nearly 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up over 86% in the past one-month time frame.
In the last 30 days, Vanda has witnessed two positive revisions and its Zacks Consensus Estimate also moved higher, suggesting more solid trading for the company going forward. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.
Vanda Pharmaceuticals currently has a Zacks Rank #1 (Strong Buy) while its Earnings ESP is 0.00%.
Some other biotechnology stocks with the same Zacks Rank include Actelion Ltd. ( ALIOF ), AMAG Pharmaceuticals, Inc. ( AMAG ) and Heska Corporation ( HSKA ).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days . Click to get this free report >>
ACTELION LTD (ALIOF): Get Free Report
AMAG PHARMA INC (AMAG): Free Stock Analysis Report
HESKA CORP (HSKA): Free Stock Analysis Report
VANDA PHARMACT (VNDA): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research